Jeffrey Church, MD
Plastic and Reconstructive Surgery · Wilmington, NCNPI 1568463131
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,549 of the $5,767 with a category attached, or 78.9%. AbbVie accounts for 93.1% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $3,397 and has fallen 92.6% since, to $251 in 2025.
Across 68 payments — averaging $84.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Sientra, Inc.$147
- Musculoskeletal Transplant Foundation Inc.$72
- Mentor Worldwide LLC$71
- Galderma Laboratories, L.p.$67
- Solta Medical, A Division Of Bausch Health US, LLC$25
- plus $17 from 1 others
What the payments were for
- Speaking & faculty fees$4,54979%
- Food & beverage$1,21821%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 53 | $5,367 |
| Sientra, Inc. | 4 | $147 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $72 |
| Mentor Worldwide LLC | 4 | $71 |
| Galderma Laboratories, L.p. | 4 | $67 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $25 |
| Merz North America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$144
How this compares
$5,767 in reported general payments places this provider in the 70th percentile of 55 plastic and reconstructive surgery providers in North Carolina.
See all plastic and reconstructive surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 27 | $92 |
| Clindamycin Hcl | 17 | $91 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $74 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Wilmington
- Charles KaysWilmington$69K
- Mark MorganWilmington$23K
- Kenneth WhiteWilmington$9K
- Tor LjungWilmington$3K
- Jeffrey MarcusDurham$3.3M
- Anuja AntonyCary$326K
- Peter ArnoldGreensboro$206K
- Joseph HunstadCharlotte$144K
- Charles HultmanRaleigh$70K
- Brian CoanCary$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.